https://www.selleckchem.com/pr....oducts/muramyl-dipep
Pralatrexate is a cost-effective intervention with improved OS and incremental costs within the WTP limit. Pralatrexate could function as a new therapeutic option for patients suffering from life-threatening R/R PTCL. Pralatrexate is a cost-effective intervention with improved OS and incremental costs within the WTP limit. Pralatrexate could function as a new therapeutic option for patients suffering from life-threatening R/R PTCL. Assessing hospital mortality and its predictors is important as some of these can be prevented t
Like
Comment
Share
